Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/07/2012WO2012118048A1 Novel macrolide intermediate and novel production process
09/07/2012WO2012117996A1 Gpr119 agonist
09/07/2012WO2012117969A1 Anti-inflammatory agent and process of producing same
09/07/2012WO2012117855A1 (nucleic acid)-polysaccharide complex
09/07/2012WO2012117421A1 Histone deacetylase inhibitors
09/07/2012WO2012117410A1 A process for the preparation of n-[2-[(acetylthio) methyl]-1-oxo-3-phenylpropyl] glycine phenyl methyl ester and intermediates thereof
09/07/2012WO2012117396A1 Tyrphostin derivative in combination with cytotoxic compounds for treating cancer
09/07/2012WO2012117377A1 Combination vaccines with lower doses of antigen and/or adjuvant
09/07/2012WO2012117362A1 Stable compositions of tetrahydrobiopterin
09/07/2012WO2012117340A1 Method for the cosmetic treatment of skin redness
09/07/2012WO2012117334A1 Mglur5 positive allosteric modulators for use in the treatment phelan-mcdermid syndrome
09/07/2012WO2012117257A1 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
09/07/2012WO2012117246A1 Phosphoramidate derivatives of 5 - fluoro - 2 ' - deoxyuridine for use in the treatment of cancer
09/07/2012WO2012117236A1 Vitamin d composition
09/07/2012WO2012117219A1 Pyrrolidine derivatives as selective glycosidase inhibitors and uses thereof
09/07/2012WO2012117216A1 N- (arylalkyl) - 1h- indole- 2 - sulfonic acid amide compounds and their therapeutic use as cannabinoid allosteric modulators
09/07/2012WO2012117097A1 Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors
09/07/2012WO2012117076A2 Baclofen and acamprosate based therapy of neurogical disorders
09/07/2012WO2012117075A2 Treatment of cerebral ischemia
09/07/2012WO2012117073A2 New compositions for treating neurological disorders
09/07/2012WO2012117062A1 Piperidinyl benzoimidazole derivatives as mpges-1 inihibitors
09/07/2012WO2012117059A1 Pharmaceutically active disubstituted pyridine derivatives
09/07/2012WO2012117048A1 Pharmaceutically active disubstituted triazine derivatives
09/07/2012WO2012117027A1 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
09/07/2012WO2012117001A1 Novel benzodioxole piperidine compounds
09/07/2012WO2012117000A1 3-amino-pyridines as gpbar1 agonists
09/07/2012WO2012116997A1 TREATMENT OF ARTERIAL AGEING BY HMG CoA REDUCTASE INHIBITOR
09/07/2012WO2012116996A1 Treatment of arterial ageing by raas inhibitor
09/07/2012WO2012116989A1 Substituted heteroaryl 2', 3', 7', 7a' - tetrahydrospiro-[pyrrole-3, 6' - pyrrolo [1, 2-c] imidazole] - 1', 2 (1h, 5'h) -diones as anticancer agents
09/07/2012WO2012116985A1 TREATMENT OF ARTERIAL AGEING BY COMBINATION OF RAAS INHIBITOR AND HMG-CoA REDUCTASE INHIBITOR
09/07/2012WO2012116976A1 Prucalopride oral solution
09/07/2012WO2012116975A1 Method for administration of a gamma secretase inhibitor
09/07/2012WO2012116965A1 Bridged piperidine derivatives
09/07/2012WO2012116935A2 Gene cluster for biosynthesis of cycloclavine
09/07/2012WO2012116859A1 Use of aldosterone receptor antagonists for treating female sexual dysfunction and migraine
09/07/2012WO2012116744A1 Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols
09/07/2012WO2012116666A1 Pyrimidine compounds inhibiting the formation of nitric oxide and prostaglandin e2, method of production thereof and use thereof
09/07/2012WO2012116644A1 Targeting anti-tumor compound and preparation method and use thereof
09/07/2012WO2012116629A1 Mangiferin aglycon derivative and preparation method and use thereof
09/07/2012WO2012116586A1 2-aminothiazole derivative, preparation method, and use
09/07/2012WO2012116585A1 Pharmaceutical use of aminothiazole myd88 specificity inhibitor
09/07/2012WO2012116577A1 Chlorogenic acid analogue, preparation process and use thereof
09/07/2012WO2012116452A1 Antimicrobial/adjuvant compounds and methods
09/07/2012WO2012116447A1 Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
09/07/2012WO2012116440A1 Benzimidazole inhibitors of the sodium channel
09/07/2012WO2012116432A1 Treatment of cancer with dopamine receptor antagonists
09/07/2012WO2012116415A1 Novel small-molecules as therapeutics
09/07/2012WO2012116410A1 Methods of treating a disease or condition of the central nervous system
09/07/2012WO2012116402A1 Binder powders
09/07/2012WO2012116391A1 Cosmetic or pharmaceutical formulation
09/07/2012WO2012097082A9 Method of optimizing 5-fu therapy
09/07/2012WO2012097052A3 Monosaccharide-based compounds for the treatment of proliferative and inflammatory dermatological diseases
09/07/2012WO2012093855A3 Novel flavi mycin compound, antifungal composition including same, and method for producing same
09/07/2012WO2012093787A3 Composition for activating gabaa benzodiazepine receptor and composition for anxiety alleviation, convulsion reduction, sedation and sleep induction and improvement containing phloroglucinol, phlorotannin or brown algae extract
09/07/2012WO2012092421A3 Composition for intravascular delivery of therapeutic composition
09/07/2012WO2012091571A3 Combination of components for the prevention and treatment of frailty
09/07/2012WO2012091153A3 Orally disintegrating tablet
09/07/2012WO2012090201A3 Methods of improving cognitive function
09/07/2012WO2012087889A3 Dna methylation inhibitors
09/07/2012WO2012085927A3 Tadalafil compositions
09/07/2012WO2012085608A3 Use of trifluoro phthalimides for the treatment of cancerous diseases
09/07/2012WO2012082618A3 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
09/07/2012WO2012080982A3 Functional food preparation and use thereof
09/07/2012WO2012080833A3 Controlled release dosage forms
09/07/2012WO2012080284A3 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
09/07/2012WO2012078982A3 Xzh-5 inhibits constitutive and interleukin-6-induced stat3 phosphorylation in human hepatocellular carcinoma cells
09/07/2012WO2012078980A3 Compositions, methods and kits for remineralization and inhibition of dental caries in teeth
09/07/2012WO2012077932A3 Novel pyrazole pyridine derivative or pharmaceutically acceptable salts thereof, method for producing same, and pharmaceutical composition including same
09/07/2012WO2012076907A3 Dosage form
09/07/2012WO2012066485A3 Agave fructans compositions and their use in mineral absorption
09/07/2012WO2012064150A3 Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseases
09/07/2012WO2012059443A3 Novel neurotrypsin inhibitors
09/07/2012WO2012039642A8 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
09/07/2012WO2012035421A3 Pyridine compounds and the uses thereof
09/07/2012WO2012026908A3 Cefpodoxime proxetil formulations comprising taste regulating agent
09/07/2012WO2012016646A9 Quetiapine tablets
09/07/2012WO2012011740A9 Method for preparing microspheres and microspheres produced thereby
09/07/2012WO2012010883A3 Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile
09/07/2012WO2011157720A3 Ivabradine-containing pharmaceutical composition with modified release
09/07/2012WO2011117145A3 Pyrrolopyrazine kinase inhibitors
09/07/2012WO2011101734A3 Taste-masked powder for suspension compositions of methylprednisolone
09/07/2012WO2011089234A8 Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
09/07/2012CA2831978A1 Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors
09/07/2012CA2829051A1 Compositions and methods comprising c16:1n7-palmitoleate
09/07/2012CA2829040A1 Non-aqueous silicone-based ophthalmic formulations
09/07/2012CA2829025A1 Derivatives of pyrazole-substituted amino-heteroaryl compounds
09/07/2012CA2828971A1 Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it
09/07/2012CA2828877A1 6-alkyl-n-(pyridin-2-yl)-4-aryloxypicolinamide analogs as mglur5 negative allosteric modulators and methods of making and using the same
09/07/2012CA2828844A1 Combination vaccines with lower doses of antigen and/or adjuvant
09/07/2012CA2828831A1 Compounds and methods for the treatment of pain and other disorders
09/07/2012CA2828801A1 2-aminothiazole derivative, preparation method, and use
09/07/2012CA2828796A1 Pharmaceutical use of aminothiazole myd88 specificity inhibitor
09/07/2012CA2828780A1 Novel small-molecules as therapeutics
09/07/2012CA2828765A1 Baclofen and acamprosate based therapy of neurological disorders
09/07/2012CA2828764A1 Anti-amyloid compounds and methods
09/07/2012CA2828763A1 New compositions for treating neurological disorders
09/07/2012CA2828748A1 Antimicrobial / adjuvant compounds and methods
09/07/2012CA2828685A1 Stable compositions of tetrahydrobiopterin
09/07/2012CA2828612A1 Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
09/07/2012CA2828524A1 Histone deacetylase inhibitors
1 ... 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 ... 7860